Anthony Peters to Humans
This is a "connection" page, showing publications Anthony Peters has written about Humans.
Connection Strength
0.848
-
Peters AE, Jones WS, Anderson B, Bramante CT, Broedl U, Hornik CP, Kehoe L, Knowlton KU, Krofah E, Landray M, Locke T, Patel MR, Psotka M, Rockhold FW, Roessig L, Rothman RL, Schofield L, Stockbridge N, Trontell A, Curtis LH, Tenaerts P, Hernandez AF. Framework of the strengths and challenges of clinically integrated trials: An expert panel report. Am Heart J. 2024 Sep; 275:62-73.
Score: 0.051
-
Peters AE, Clare RM, Chiswell K, Harrington J, Kelsey A, Hernandez A, Felker GM, Mentz RJ, DeVore AD. Implications of trial eligibility in patients with heart failure with mildly reduced or preserved ejection fraction. ESC Heart Fail. 2024 Oct; 11(5):2813-2824.
Score: 0.051
-
Peters AE, Mentz RJ, Greene SJ. Advancing the evidence for diuretic therapy for heart failure: implications of the ADVOR and TRANSFORM-HF trials. Eur Heart J Cardiovasc Pharmacother. 2023 Jun 02; 9(4):299-300.
Score: 0.048
-
Peters AE, Kraus WE, Mentz RJ. New Paradigms to Address Long-Term Exercise Adherence, An Achilles Heel of Lifestyle Interventions. Circulation. 2023 May 23; 147(21):1565-1567.
Score: 0.048
-
Peters AE, Clare RM, Chiswell K, Felker GM, Kelsey A, Mentz R, DeVore AD. Echocardiographic Features Beyond Ejection Fraction and Associated Outcomes in Patients With Heart Failure With Mildly Reduced or Preserved Ejection Fraction. Circ Heart Fail. 2023 May; 16(5):e010252.
Score: 0.048
-
Peters AE, Tromp J, Shah SJ, Lam CSP, Lewis GD, Borlaug BA, Sharma K, Pandey A, Sweitzer NK, Kitzman DW, Mentz RJ. Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions. Cardiovasc Res. 2023 Feb 03; 118(18):3403-3415.
Score: 0.047
-
Peters AE, Wu A, Chiswell K, Hofmann P, Nkulikiyinka R, Dinh W, Piccini JP, Mentz RJ, Fudim M. Continuous Monitoring of Heart Rate Variability and Clinical Outcomes in Patients with Implantable Cardioverter Defibrillators. Curr Probl Cardiol. 2023 Mar; 48(3):101520.
Score: 0.046
-
Peters AE, Ogunniyi MO, Hegde SM, Bianco C, Ghafghazi S, Hernandez AF, DeVore AD. A multicenter program for electronic health record screening for patients with heart failure with preserved ejection fraction: Lessons from the DELIVER-EHR initiative. Contemp Clin Trials. 2022 Oct; 121:106924.
Score: 0.045
-
Peters AE, Chiswell K, Hofmann P, Ambrosy A, Fudim M. Characteristics and Outcomes of Suspected Digoxin Toxicity and Immune Fab Treatment Over the Past Two Decades-2000-2020. Am J Cardiol. 2022 Nov 15; 183:129-136.
Score: 0.045
-
Peters AE, DeVore AD. Pharmacologic Therapy for Heart Failure with Preserved Ejection Fraction. Cardiol Clin. 2022 Nov; 40(4):473-489.
Score: 0.045
-
Peters AE, Kitzman DW, Chen H, Nelson MB, Pastva AM, Duncan PW, Reeves GR, Upadhya B, Whellan DJ, Mentz RJ. Obesity Status and Physical Rehabilitation in Older Patients Hospitalized With Acute HF: Insights From REHAB-HF. JACC Heart Fail. 2022 Dec; 10(12):918-927.
Score: 0.045
-
Peters AE, Mentz RJ, Sun JL, Harrington JL, Fudim M, Alhanti B, Hernandez AF, Butler J, Starling RC, Greene SJ. Patient-reported and Clinical Outcomes Among Patients Hospitalized for Heart Failure With Reduced Versus Preserved Ejection Fraction. J Card Fail. 2022 Dec; 28(12):1652-1660.
Score: 0.045
-
Peters AE, Mentz RJ, DeWald TA, Greene SJ. An evaluation of torsemide in patients with heart failure and renal disease. Expert Rev Cardiovasc Ther. 2022 Jan; 20(1):5-11.
Score: 0.043
-
Peters AE, Pandey A, Ayers C, Wegermann K, McGarrah RW, Grodin JL, Abdelmalek MF, Bekfani T, Blumer V, Diehl AM, Moylan CA, Fudim M. Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCAT. ESC Heart Fail. 2021 Apr; 8(2):842-848.
Score: 0.041
-
Peters AE, Mazimba S. Author's Response to Imamura and Colleagues. J Card Fail. 2019 Aug; 25(8):699.
Score: 0.036
-
Peters AE, Smith LA, Ababio P, Breathett K, McMurry TL, Kennedy JLW, Abuannadi M, Bergin J, Mazimba S. Comparative Analysis of Established Risk Scores and Novel Hemodynamic Metrics in Predicting Right Ventricular Failure in Left Ventricular Assist Device Patients. J Card Fail. 2019 Aug; 25(8):620-628.
Score: 0.036
-
Peters AE, Keeley EC. Trends and Predictors of Participation in Cardiac Rehabilitation Following Acute Myocardial Infarction: Data From the Behavioral Risk Factor Surveillance System. J Am Heart Assoc. 2017 Dec 29; 7(1).
Score: 0.033
-
Peters AE, Keeley EC. Patient Engagement Following Acute Myocardial Infarction and Its Influence on Outcomes. Am J Cardiol. 2017 Nov 01; 120(9):1467-1471.
Score: 0.032
-
Peters A, Brey DM, Burdick JA. High-throughput and combinatorial technologies for tissue engineering applications. Tissue Eng Part B Rev. 2009 Sep; 15(3):225-39.
Score: 0.018
-
Foulkes SJ, Hewitt D, Peters A, Schmidt T, Reiss N, Riess K, Paterson S, La Gerche A, Haykowsky MJ. Effect of Exercise Training on Peak Aerobic Power After Heart Transplantation: A Brief Review. Can J Cardiol. 2023 Nov; 39(11S):S368-S374.
Score: 0.012
-
Pierce JB, Ikeaba U, Peters AE, DeVore AD, Chiswell K, Allen LA, Albert NM, Yancy CW, Fonarow GC, Greene SJ. Quality of Care and Outcomes Among Patients Hospitalized for Heart Failure in Rural vs Urban US Hospitals: The Get With The Guidelines-Heart Failure Registry. JAMA Cardiol. 2023 Apr 01; 8(4):376-385.
Score: 0.012
-
Weatherald J, Boucly A, Peters A, Montani D, Prasad K, Psotka MA, Zannad F, Gomberg-Maitland M, McLaughlin V, Simonneau G, Humbert M. The evolving landscape of pulmonary arterial hypertension clinical trials. Lancet. 2022 Nov 26; 400(10366):1884-1898.
Score: 0.012
-
Smith L, Peters A, Mazimba S, Ragosta M, Taylor AM. Outcomes of patients with cardiogenic shock treated with TandemHeart® percutaneous ventricular assist device: Importance of support indication and definitive therapies as determinants of prognosis. Catheter Cardiovasc Interv. 2018 Nov 15; 92(6):1173-1181.
Score: 0.008